For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Rho associated coiled-coil containing protein kinase 2 is a protein that in humans is encoded by the ROCK2 gene. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1, is a target for the small GTPase Rho.
Scope of the Report:
In the last several years, global market of Rho Associated Protein Kinase 2 developed rapidly, with an average growth rate of 68%. In 2017, Global Market Size of Rho Associated Protein Kinase 2 is nearly 850 K USD.
For developing product, there are 1 product in Phase 3, 2 products in Phase 2, 0 products in Phase 1 and 6 products in Preclinical. The total investment for Rho Associated Protein Kinase 2 developing is around 88 M USD in 2017.
The Application of Rho Associated Protein Kinase 2 includes Glaucoma, Spinal Cord, Chronic Obstructive Pulmonary Disease, Immune Therapy and Others, and the proportion of R&D Investmen for Glaucoma in 2017 is about 67%, and the proportion is in decrease trend from 2012 to 2016.
The worldwide market for Rho Associated Protein Kinase 2 is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Rho Associated Protein Kinase 2 in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Aerie Pharmaceuticals
- Kadmon Corporation
- BioAxone BioSciences Inc
- Redx Pharma
- Angion Biomedica
- DWTI
- HitGen LTD
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Type I
- Type II
Market Segment by Applications, can be divided into
- Glaucoma
- Spinal Cord
- Chronic Obstructive Pulmonary Disease
- Immune Therapy
- Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rho Associated Protein Kinase 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rho Associated Protein Kinase 2, with price, sales, revenue and global market share of Rho Associated Protein Kinase 2 in 2017 and 2018.
Chapter 3, the Rho Associated Protein Kinase 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rho Associated Protein Kinase 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Rho Associated Protein Kinase 2 market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Rho Associated Protein Kinase 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.